BBVA USA Bancshares’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$499K Sell
7,370
-515
-7% -$35.7K 0.02% 401
2020
Q4
$577K Buy
7,885
+1,581
+25% +$115K 0.03% 367
2020
Q3
$455K Buy
6,304
+163
+3% +$12.8K 0.03% 373
2020
Q2
$446K Buy
6,141
+565
+10% +$40.2K 0.03% 377
2020
Q1
$344K Buy
5,576
+396
+8% +$24.2K 0.02% 382
2019
Q4
$339K Buy
5,180
+1,577
+44% +$108K 0.02% 429
2019
Q3
$285K Buy
+3,603
New +$241K 0.02% 330
2018
Q3
Sell
-3,896
Closed -$227K 552
2018
Q2
$227K Buy
+3,896
New +$211K 0.01% 494
2018
Q1
Sell
-3,535
Closed -$210K 545
2017
Q4
$210K Buy
3,535
+107
+3% +$6.49K 0.01% 514
2017
Q3
$202K Buy
+3,428
New +$204K 0.01% 512

Other funds holding CONE

BBVA USA Bancshares's CONE Position: Q1 2021 in Review

BBVA USA Bancshares reduced its CyrusOne Inc Common Stock (CONE) stake by 6.5% in Q1 2021, selling an estimated $35.7K and leaving 7,370 shares worth $499K. The position accounts for 0.02% of the portfolio, ranked #401.

BBVA USA Bancshares first reported a position in CONE in Q3 2017 and has held it in 10 quarters since. The position peaked at $577K in Q4 2020. 412 funds tracked by Wall St. Rank hold CONE as of Q1 2021.

  • BBVA USA Bancshares held 7,370 shares of CyrusOne Inc Common Stock worth $499K as of Q1 2021.
  • BBVA USA Bancshares sold 515 CyrusOne Inc Common Stock shares in Q1 2021, an estimated $35.7K.
  • CyrusOne Inc Common Stock made up 0.02% of BBVA USA Bancshares's portfolio in Q1 2021, its #401 holding.
  • BBVA USA Bancshares first reported a position in CyrusOne Inc Common Stock in Q3 2017 and has held it in 10 quarters since.
  • BBVA USA Bancshares's CyrusOne Inc Common Stock position peaked at $577K in Q4 2020.
  • 412 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.